82 T Ta ab bl le e d de es s m ma at ti iè èr re es s ,
10 I.3.3 Les enjeux économiques et pratiques : préparation à l'avance, gain de temps, économies, confort du patient et dosebanding ,
35 III.3 King Guide to parenteral admixtures, ., p.36 ,
38 IV.1 Historique et présentation de la base de données, p.38 ,
51 I.3 3 ème phase : travail individuel de cotation des publications relatives aux études de stabilité des médicaments anticancéreux, 56 I.3.1 Inventaire des publications à, p.56 ,
97 III.3.8 Mais où sont les produits de dégradation ?, III.3.7 D comme Différents cas, p.97 ,
Définition de la stabilité Page consultée le 13 avril 2013 ,
Stability of Azacitidine Suspensions, Annals of Pharmacotherapy, vol.41, issue.4, p.546, 2011. ,
DOI : 10.1345/aph.1P431
Stability of azacitidine in infusion fluids ,
Stability of azacitidine in lactated Ringer's injection frozen in polypropylene syringes, Am J Hosp Pharm, vol.46, pp.2500-2505, 1989. ,
Résumé des caractéristiques du produit Vidaza ®. 89 ème éd, p.2527 ,
Long-term stability of bevacizumab repackaged in 1mL polypropylene syringes for intravitreal administration, Annales Pharmaceutiques Fran??aises, vol.70, issue.3, pp.139-154, 2012. ,
DOI : 10.1016/j.pharma.2012.03.006
Stability Study of Epirubicin in Nacl 0.9% Injection, Annals of Pharmacotherapy, vol.8, issue.9, pp.992-995, 1997. ,
DOI : 10.1002/jps.2600510902
Pharmaceutical aspects of home infusion therapy for cancer patients, Pharm J, vol.238, pp.476-478, 1987. ,
Suitability of cisplatin solutions for 14-day continuous infusion by ambulatory pump, Cancer Chemotherapy and Pharmacology, vol.2, issue.Suppl 3, pp.252-255, 1992. ,
DOI : 10.1007/BF00686261
Stability of three cytotoxic drug infusions in the Graseby 9000 ambulatory infusion pump, Journal of Oncology Pharmacy Practice, vol.3, issue.3, pp.143-149, 1998. ,
DOI : 10.1177/107815529700300304
Stability of doxorubicin and vincristine sulfate in two portable infusion-pump reservoirs, Am J Health-Syst, vol.53, pp.1171-1173, 1996. ,
Stability of intraveinous admixtures of doxorubicin and vincristine, Am J Hosp Pharm, vol.43, pp.3022-3027, 1986. ,
Stability of intravenous admixtures of doxorubicin and vincristine confirmed by LC-MS ,
Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration, Am J Health-Syst Pharm, vol.54, pp.56-60, 1997. ,
Stability of ondansetron hydrochloride and five antineoplasic medications, Am J Health-Syst Pharm, vol.53, pp.1297-1300, 1996. ,
Cytosine Arabinoside Stability in Intravenous Admixtures with Sodium Bicarbonate and in Plastic Syringes, Drug Intelligence & Clinical Pharmacy, vol.61, issue.10, pp.765-767, 1982. ,
DOI : 10.1002/jps.2600610803
Stability studies of drugs used in oncology: the role of the hospital pharmacists, EJHP Practice, vol.12, issue.6, pp.75-76, 2006. ,
SFPO and ESOP recommendations for the practical stability of anticancer drugs: An update, Annales Pharmaceutiques Fran??aises, vol.71, issue.6, p.2013 ,
DOI : 10.1016/j.pharma.2013.06.002
Extended stability of rituximab, bortezomib and azacitidine : application in the daily practice in haematology, EJOP, vol.6, issue.2, pp.12-13, 2012. ,
Résumé des caractéristiques du produit Velcade®. 89 ème éd, p.2493 ,
Etude de la stabilité d'une solution de Bortezomib à 1 mg/mL conditionnée en seringue de polypropylène -Application à la production quotidienne d'une unité de production centralisée de préparation de cytotoxiques pour le service d'hospitalisation de jour d'Hématologie, 2011. ,
Mémoire de DES Pharmacie-Etude de la stabilité d'une solution de bortezomib à 2, p.5 ,
Guidelines for the pratical stability studies of anticancer drugs : A European consensus conference, Ann Pharm Fr, vol.69, pp.221-231, 2011. ,
Development of validated stability-indicating assay methods???critical review, Journal of Pharmaceutical and Biomedical Analysis, vol.28, issue.6, pp.1011-1040, 2002. ,
DOI : 10.1016/S0731-7085(02)00047-X
Practical and regulatory considerations for stability-indicating methods for the assay of bulk drugs and drug formulations, TrAC Trends in Analytical Chemistry, vol.49, 2013. ,
DOI : 10.1016/j.trac.2013.05.008
Stability indicating HPLC method development ? a review ,
An overview of the recent trends in development of HPLC methods for determination of impurities in drugs, J Pharm Biomed Anal, vol.33, pp.335-337, 2003. ,
Department of Health and Human Services. Guidance for Industry, Analytical Procedures and Method Validation, pp.25-2013, 2010. ,
High-Performance liquid chromatography for small-scales studies of drug stability, Am J ,
Essai 2.2.1 :Clarity and degree of opalescence of liquids, 517605. ,
Essai 2.9.19. Particulate contamination: sub-visible particles, 21624. ,
Stability-indicating HPLC methods for drug analysis, p.904, 1999. ,
Chemical Stability of Pharmaceuticals : A Handbook for Pharmacists, p.864, 1986. ,
Forced degradation and impurity profiling: Recent trends in analytical perspectives, Journal of Pharmaceutical and Biomedical Analysis, vol.86, pp.11-35, 2013. ,
DOI : 10.1016/j.jpba.2013.07.013
Forced Degradation an Integral Part of HPLC Stability-indicating Method Development ,
Available Guidance and Best Practices for Conducting Forced Degradation Studies, Pharm Technol, vol.26, issue.2, pp.48-56, 2002. ,
Developing and validating Stability-Indicating Methods, LCGC North America, vol.23, issue.6, pp.586-593, 2005. ,
Analytical methodologies for discovering and profiling degradation-related impurities, TrAC Trends in Analytical Chemistry, vol.25, issue.8, pp.758-767, 2006. ,
DOI : 10.1016/j.trac.2006.05.012
The importance and the challenges of impurity profiling in modern pharmaceutical analysis, TrAC Trends in Analytical Chemistry, vol.25, issue.8, pp.755-757, 2006. ,
DOI : 10.1016/j.trac.2006.05.011
The role of analytical chemistry in drug-stability studies, TrAC Trends in Analytical Chemistry, vol.49, pp.55-56, 2013. ,
DOI : 10.1016/j.trac.2013.06.001
Advances in HPLC technology for the determination of drug impurities, TrAC Trends in Analytical Chemistry, vol.25, issue.8, pp.796-805, 2006. ,
DOI : 10.1016/j.trac.2006.06.005
Stability-Indicating Assays, LCGC North America, vol.20, issue.4, pp.346-349, 2002. ,
Labostat Guide de validation des méthodes d'analyse, p.361 ,
Relevant shaking stress conditions for antibody preformulation development, European Journal of Pharmaceutics and Biopharmaceutics, vol.74, issue.2, pp.139-147, 2010. ,
DOI : 10.1016/j.ejpb.2009.11.005
Monoclonal antibodies as therapeutic agents for cancer, The Lancet Oncology, vol.5, issue.5, pp.292-302, 2004. ,
DOI : 10.1016/S1470-2045(04)01467-6
Mechanically-induced aggregation of the monoclonal antibody cetuximab, Annales Pharmaceutiques Fran??aises, vol.67, issue.5, pp.340-352, 2009. ,
DOI : 10.1016/j.pharma.2009.05.008
Stability of Protein Pharmaceuticals: An Update, Pharmaceutical Research, vol.74, issue.48, pp.544-575, 2010. ,
DOI : 10.1016/j.bbapap.2006.05.013
Formulation and delivery issues for monoclonal antibody therapeutics ,
DOI : 10.1007/978-0-387-76643-0_8
Stability Assessment and Formulation Charaterization, Handbook of Pharmaceutical Biotechnology, p.1660, 2007. ,
Protein aggregation???Pathways and influencing factors, International Journal of Pharmaceutics, vol.390, issue.2 ,
DOI : 10.1016/j.ijpharm.2010.02.025
Stability of Proteins Small Globular Proteins, Adv Protein Chem, vol.33, pp.167-241, 1979. ,
DOI : 10.1016/S0065-3233(08)60460-X
Chemical denaturation as a tool in the formulation optimization of biologics, Drug Discovery Today, vol.18, issue.19-20, 2013. ,
DOI : 10.1016/j.drudis.2013.06.005
What makes protein drugs different ? Pharmaceutical aspects, EJHP Practice, pp.20-21, 2006. ,
What makes protein drugs different ? Some considerations of shifting paradigms in Pharmacy. EJHP Practice, pp.14-16, 2006. ,
Protein aggregation and its inhibition in biopharmaceutics, International Journal of Pharmaceutics, vol.289, issue.1-2, pp.1-30, 2005. ,
DOI : 10.1016/j.ijpharm.2004.11.014
Mechanisms of Protein Aggregation, Current Pharmaceutical Biotechnology, vol.10, issue.4, pp.348-351, 2009. ,
DOI : 10.2174/138920109788488932
Protein Therapeutics and Their Immunogenicity. EJHP Practice, pp.17-18, 2006. ,
Immunogenicity of biopharmaceuticals, Nephrology Dialysis Transplantation, vol.21, issue.suppl_5, pp.9-12, 2006. ,
DOI : 10.1196/annals.1313.027
Bioequivalence and the immunogenicity of biopharmaceuticals, Nature Reviews Drug Discovery, vol.13, issue.6, pp.457-462, 2002. ,
DOI : 10.1007/BF02990843
Immunogenicity of different stressed IgG monoclonal antibody formulations in immune tolerant transgenic mice, mAbs, vol.102, issue.6, pp.740-752, 2012. ,
DOI : 10.1016/j.jim.2010.09.005
The immunogenicity of Therapeutics proteins, Discovery Medicine, vol.9, issue.49, pp.560-564, 2010. ,
Factors affecting short-term and long-term stabilities of proteins, Advanced Drug Delivery Reviews, vol.46, issue.1-3, pp.307-326, 2001. ,
DOI : 10.1016/S0169-409X(00)00144-7
Stability of cetuximab and panitumumab in glass vials and polyvinyl chloride bags, American Journal of Health-System Pharmacy, vol.67, issue.3, pp.223-226, 2010. ,
DOI : 10.2146/ajhp090031
Stability of stock and diluted rituximab, American Journal of Health-System Pharmacy, vol.70, issue.5, pp.436-438, 2013. ,
DOI : 10.2146/ajhp120035
Long-term stability of diluted solutions of the monoclonal antibody rituximab, International Journal of Pharmaceutics, vol.436, issue.1-2, pp.282-290, 2012. ,
DOI : 10.1016/j.ijpharm.2012.06.063
Pharmacie Hospitalière et des Collectivités ? Création d'une base de données sur CD-Rom, conçue dans un langage international à base de pictogrammes, concernant la stabilité et la compatibilité des médicaments injectables, 2000. ,
Identifying the criteria of a valid stability study, Int J Pharm Compound, vol.13, pp.32-36, 2009. ,
SFPO and ESOP recommendations for the practical stability of anticancer drugs, EJOP, vol.4, issue.3, pp.7-10, 2010. ,
Stability and compatibility studies of vinblastine, vincristine, vindesine and vinorelbine with PVC infusion bags, International Journal of Pharmaceutics, vol.77, issue.2-3, pp.279-285, 1991. ,
DOI : 10.1016/0378-5173(91)90328-L
THE STABILITY OF CARBOPLATIN IN AMBULATORY CONTINUOUS INFUSION REGIMES, Journal of Clinical Pharmacy and Therapeutics, vol.44, issue.6, pp.427-432, 1987. ,
DOI : 10.1097/00000421-198510000-00017
Stability study of 5-fluorouracil following repackaging in plastic disposable syringes and multidose vials, Am J IV Ther Clin Nut, vol.9, pp.23-25, 1982. ,
Stability of carmustine -kinetics and compatibility during administration, Acta Pharm Suec, vol.23, pp.115-124, 1986. ,
The extraction of diethylhexylphtalate (DEHP) from polyvinyl chloride components of intravenous infusion containers and administration sets by paclitaxel injection, Int J ,
Leaching of diethylhexyl phthalate from polyvinyl chloride containers by selected drugs and formulation components, Am J Hosp Pharm, vol.50, pp.1405-1409, 1993. ,
Compatibility of paclitaxel injection vehicle with intravenous administration and extension sets, Am J Hosp Pharm, vol.51, pp.2804-2810, 1994. ,
Compatibility of docetaxel and paclitaxel in intravenous solutions with polyvinyl chloride infusion materials, Am J Health-Syst Pharm, vol.54, pp.566-569, 1997. ,
Stability, compatibility, and plasticizer extraction of taxol (NSC- 125973) injection diluted in infusion solutions and stored in various containers, Am J Hosp Pharm, vol.48, pp.1520-1524, 1991. ,
Investigation of the release behavior of DEHP from infusion sets by paclitaxel-loaded polymeric micelles, International Journal of Pharmaceutics, vol.293, issue.1-2, pp.303-310, 2005. ,
DOI : 10.1016/j.ijpharm.2005.01.011
Precipitation of fluorouracil in elastomeric infusers with a polyisoprene reservoir and in polypropylene syringes with an elastomeric joint, Am J Health-Syst Pharm, vol.54, pp.1845-1848, 1997. ,
Fluorouracil precipitate, Am J Health-Syst Pharm, vol.55, pp.1315-1316, 1998. ,
Summerfield M, Stability of carmustine in the presence of sodium bicarbonate ,
Conditions causing gemcitabine crystallization, Journal of Oncology Pharmacy Practice, vol.5, issue.4, pp.395-399, 2011. ,
DOI : 10.1016/j.urology.2004.08.027
The stability of melphalan in the presence of chloride ion???, Journal of Pharmacy and Pharmacology, vol.4, issue.1 ,
DOI : 10.1007/978-1-4684-1378-6_5
A stability-indicating, ion-pairing, reversed-phase liquid chromatography method for studies of daunorubicin degradation in i.v. infusion fluids, Journal of Pharmaceutical and Biomedical Analysis, vol.83, pp.164-170, 2013. ,
DOI : 10.1016/j.jpba.2013.05.007
Physicochemical and biological stability of diluted rituximab solutions stored 6 months at 4°C. Congrès ECCO, 2011. ,
Stability of diluted L-asparaginase in normal saline solution. Congrès ECCO, 2011. ,
Physicochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags, Int J Pharm Compound, vol.15, issue.6, pp.515-520, 2011. ,
Stability of alemtuzumab in infusion bags, Pharmazie, vol.64, issue.9, pp.622-623, 2009. ,
Etats des lieux : Niveau de preuve et gradation des recommandations de bonne pratique, 2013. ,
Accréditation et d'Evaluation en Santé. Guide d'analyse de la littérature et gradation des recommandations, 2000. ,
Recommandations, niveaux de preuve, EBM et décision médicale, 2013. ,
Les systèmes de notation. Tangente éducation, pp.1-5, 2008. ,
Induction and analysis of aggregates in a liquid IgG1-antibody formulation, European Journal of Pharmaceutics and Biopharmaceutics, vol.59, issue.3, pp.407-417, 2005. ,
DOI : 10.1016/j.ejpb.2004.12.004
Concentration-dependent incompatibility of vinorelbine tartrate and heparin sodium ,
Stability of mitomycin C in different infusion fluids: Compatibility with heparin and glucocorticosteroids, Journal of Oncology Pharmacy Practice, vol.15, issue.3, pp.19-24, 1995. ,
DOI : 10.1007/BF02280051
Stability after freezing and thawing of solutions of mitomycin C in plastic minibags for intravesical use, Pharmaceutisch Weekblad Scientific Edition, vol.43, issue.6, pp.286-288, 1986. ,
DOI : 10.1007/BF01959778
An NMR Study of the Bortezomib Degradation under Clinical Use Conditions. Advance in Haematology, p.5, 2009. ,
Stability of fluorouracil in plastic containers used for continuous infusion at home, Am J Hosp Pharm, vol.41, pp.1153-1156, 1984. ,
Compatibility and Stability of Paclitaxel Combined with Cisplatin and with Carboplatin in Infusion Solutions, Annals of Pharmacotherapy, vol.50, issue.12, pp.1465-1470, 1997. ,
DOI : 10.1111/j.1365-2710.1994.tb01118.x
Stability of fluorouracil in polypropylene syringes and ethylene vinyl acetate infusion-pump reservoirs, Am J Health-Syst Pharm, vol.53, pp.1457-1458, 1996. ,
Stability of solutions of doxorubicin and epirubicin in plastic minibags for intravesical use after storage at ???20?? C and thawing by microwave radiation, Pharmaceutisch Weekblad, vol.71, issue.3, pp.194-197, 1986. ,
DOI : 10.1007/BF01968712
Evaluation of some pharmaceutical aspects of intrathecal methotrexate sodium, cytarabine and hydrocortisone sodium succinate, Am J Hosp Pharm, vol.35, pp.402-406, 1978. ,
Stability of paclitaxel and fluconazole during simulated Y-site administration, Am J Hosp Pharm, vol.51, pp.2704-2706, 1994. ,
Five-day stability of vinorelbine in 5% dextrose injection and in 0.9% sodium chloride injection at room temperature, Int J Pharm Compound, vol.3, pp.67-68, 1999. ,
Stability study of fotemustine in PVC infusion bags and sets under various conditions using a stability-indicating high-performance liquid chromatographic assay, J Pharm Biomed Anal, vol.18, pp.373-381, 1998. ,
Compatibility and stability of pertuzumab and trastuzumab admixtures in i.v. infusion bags for coadministration, J Pharm ,
Stability of alemtuzumab solutions at room temperature, American Journal of Health-System Pharmacy, vol.70, issue.5, pp.439-442, 2013. ,
DOI : 10.2146/ajhp110632
Stability of stock and diluted rituximab, American Journal of Health-System Pharmacy, vol.70, issue.5, pp.436-438, 2013. ,
DOI : 10.2146/ajhp120035
URL : http://europepmc.org/articles/pmc3987107?pdf=render
Assays for biological agents, American Journal of Health-System Pharmacy, vol.70, issue.13, p.1101, 2013. ,
DOI : 10.2146/ajhp130128